×
About 4,410 results

ALLMedicine™ Hepatic Encephalopathy Center

Research & Reviews  1,506 results

Controlling nutritional status score as a new indicator of overt hepatic encephalopathy...
https://doi.org/10.1016/j.clnu.2021.12.036
Clinical Nutrition (Edinburgh, Scotland); Li J, Feng D et. al.

Jan 16th, 2022 - The Controlling Nutritional Status (CONUT) score is designed to assess the immune-nutritional status of patients. Poor nutritional status and inflammation may facilitate the development of hepatic encephalopathy (HE) in cirrhotic patients. However...

Liver volume based prediction model for patients with hepatitis B virus-related acute-o...
https://doi.org/10.1002/jhbp.1112
Journal of Hepato-biliary-pancreatic Sciences; Hu C, Jiang N et. al.

Jan 15th, 2022 - Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a life-threatening disease with high short-term mortality. Early and accurate prognosis is significant for clinical decision, in which liver volume (LV) impart important inform...

Diagnosis of Pulmonary Embolism on 99mTc-Labeled Macroaggregated Albumin Lung Imaging A...
https://doi.org/10.1097/RLU.0000000000004026
Clinical Nuclear Medicine; Frazzitta AE, Kay MD et. al.

Jan 14th, 2022 - A 54-year-old man with hepatocellular carcinoma from alcohol-induced cirrhosis presented with hepatic encephalopathy and refractory ascites related to decompensated liver disease. MRI confirmed disease progression adjacent the site of prior radiof...

CT-Based radiomics model for preoperative prediction of hepatic encephalopathy after tr...
https://doi.org/10.1259/bjr.20210792
The British Journal of Radiology; Cheng S, Yu X et. al.

Jan 13th, 2022 - To develop and evaluate a machine learning-based CT radiomics model for the prediction of hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS). A total of 106 patients who underwent TIPS placement were consecutive...

An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirr...
https://doi.org/10.14309/ajg.0000000000001608
The American Journal of Gastroenterology; Louissaint J, Grzyb K et. al.

Jan 13th, 2022 - Rifaximin use in combination with lactulose is associated with a decreased risk of overt hepatic encephalopathy (HE). We prospectively evaluated the impact of an interruptive electronic medical record alert to indicate rifaximin for patients with ...

see more →

Guidelines  5 results

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160350
Clinical and Molecular Hepatology;

Jan 11th, 2020 - KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.|2020| ,|

Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767982
World Journal of Gastroenterology; Xu XY, Ding HG et. al.

Oct 3rd, 2019 - The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and...

Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediat...
https://doi.org/10.1016/j.bbmt.2017.08.035
Biology of Blood and Marrow Transplantation : Journal of ... Ovchinsky N, Frazier W et. al.

Sep 6th, 2017 - Some patients with veno-occlusive disease (VOD) have multiorgan dysfunction, and multiple teams are involved in their daily care in the pediatric intensive care unit. Cardiorespiratory dysfunction is critical in these patients, requiring immediate...

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885589
European Journal of Gastroenterology & Hepatology; Shawcross DL, Dunk AA et. al.

Nov 26th, 2015 - Hepatic encephalopathy is defined as brain dysfunction caused by liver insufficiency and/or portosystemic shunting. Symptoms include nonspecific cognitive impairment, personality changes and changes in consciousness. Overt (symptomatic) hepatic en...

Review article: the design of clinical trials in hepatic encephalopathy--an Internation...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971432
Alimentary Pharmacology & Therapeutics; Bajaj JS, Cordoba J et. al.

Feb 11th, 2011 - The clinical classification of hepatic encephalopathy is largely subjective, which has led to difficulties in designing trials in this field. To review the current classification of hepatic encephalopathy and to develop consensus guidelines on the...

see more →

Drugs  19 results see all →

Clinicaltrials.gov  109 results

Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy
https://clinicaltrials.gov/ct2/show/NCT05070351

Jan 5th, 2022 - A total of 40 patients taking proton pump inhibitors (PPIs) who undergo transjugular intrahepatic portosystemic shunt (TIPS) creation as part of routine clinical care will be randomized in 1:1 fashion to either continue or discontinue their PPIs t...

Trial of Rifaximin in Probable Alzheimer's Disease
https://clinicaltrials.gov/ct2/show/NCT03856359

Dec 17th, 2021 - This study aims to improve cognition and function in patients with Alzheimer's Disease (AD) by administering the oral antibiotic, rifaximin. Rifaximin is a virtually non-absorbed antibiotic with the unique properties of altering gut microbiota and...

Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
https://clinicaltrials.gov/ct2/show/NCT01846663

Dec 15th, 2021 - The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy.

Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
https://clinicaltrials.gov/ct2/show/NCT03633279

Dec 14th, 2021 - Globally, the mortality after any infection in cirrhosis patients is very high. The cumulative mortality in patients with infections was 43.5% (11,987 patients) where as the mortality rate without infection was 13.6% (2317 patients). Over the year...

8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding
https://clinicaltrials.gov/ct2/show/NCT02477384

Dec 2nd, 2021 - For the prevention of recurrent esophageal variceal bleeding, previous clinical studies and meta-analysis show that patients treated with transjugular intrahepatic portosystemic shunt (TIPS) have lower rebleeding rates compared with endoscopic the...

see more →

News  122 results

Scoring/Classifying Patients With Advanced HCC
https://www.onclive.com/view/scoring-classifying-patients-with-advanced-hcc

Sep 2nd, 2021 - Tanios S. Bekaii-Saab, MD, FACP: Anjana, one of the most confusing elements, but one that has been ingrained so heavily into how we select patients for therapies is how we score liver function, and we still rely on a system from the 1970s. Give an...

Fedratinib for Patients With Primary Myelofibrosis
https://www.onclive.com/view/fedratinib-for-patients-with-primary-myelofibrosis

Jul 14th, 2021 - Ruben Mesa, MD, FACP: We had a new drug developed and approved in 2019. We’ve had an updated analysis that’s giving us a framework of the role of fedratinib in the frontline and second-line settings. Pankit, why don’t you share with us a bit? What...

Does MELD need an update?
https://www.mdedge.com/gihepnews/article/242286/liver-disease/does-meld-need-update
Julie K. Heimbach, MD, Jasmohan S. Bajaj, MD, AGAF

Jul 1st, 2021 - Dear colleagues and friends, The Perspectives series continues! There are few issues in our discipline that are as challenging, and controversial, as liver transplant prioritization. The Model for End-Stage Liver Disease (MELD) has been the mainst.

Screening Vs Diagnosis: Assessing Liver Function
https://www.onclive.com/view/screening-vs-diagnosis-assessing-liver-function

Apr 2nd, 2021 - Transcript: Richard S. Finn, MD: Alpha-fetoprotein [AFP] has been around for a long time, right? How do you approach the use of AFP in diagnosing patients with liver cancer? Pierre Gholam, MD: As an AFP enthusiast, we have had a love-hate re...

The Evolving Role of Medical Oncologists and Hepatologists
https://www.onclive.com/view/the-evolving-role-of-medical-oncologists-and-hepatologists

Apr 2nd, 2021 - Transcript: Peter Galle, MD: The history goes in a way that until 2002, when we had the definition of TACE [trans-arterial chemoembolization] as a successful treatment, we basically had surgery. That was transplantation, resection, and not muc...

see more →

Patient Education  3 results see all →